ClinConnect ClinConnect Logo
Search / Trial NCT06357546

Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Apr 4, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Catheterization Urethral Cesarean Section Postpartum Urinary Retention

ClinConnect Summary

This clinical trial is looking at whether it is necessary to place a bladder catheter (a tube for draining urine) during a planned cesarean section (C-section) if the patient can urinate naturally before the surgery. The researchers believe that if patients can urinate in the hour leading up to the C-section, they might not need a catheter, which could help reduce the chance of complications related to bladder drainage after the surgery.

To be eligible for this trial, women must be adults, expecting a single or twin baby, and scheduled for a C-section after 34 weeks of pregnancy with spinal anesthesia. However, women with certain medical conditions or complications, such as infections or severe pregnancy-related issues, will not be included. Participants can expect to help researchers understand if skipping the catheter could be safe and beneficial, as well as share their experiences during the process. This study is currently recruiting participants, and informed consent will be obtained from those who qualify.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Adult patient
  • Patient admitted for a planned cesarean section after 34 weeks under spinal anesthesia
  • Single or twin pregnancy
  • Unscarred or with one or two scars of the uterus
  • Exclusion Criteria:
  • Positive urine test strip showing a presence of nitrites or leukocytes, the day before the surgery suggesting asymptomatic bacteriuria
  • Emergency Caesarean
  • Scheduled Caesarean section with intervention delayed beyond 3 p.m. for service organization reasons
  • Epidural anesthesia
  • Contraindication to spinal anesthesia (uncorrected hypovolemia; blood coagulation disorders; sepsis or severe inflammation at the puncture site; neurological deficit; migraine pattern; spinal cord disease; spinal malformation; febrile syndrome)
  • ASA (American Society of Anesthesiologists) score ≥ 4
  • Placental insertion abnormality (placenta previa and/or accreta)
  • Medical indication for monitoring of diuresis
  • Oliguria or renal failure
  • Indication for use of intrathecal clonidine during scheduled cesarean section
  • History of bladder surgery or surgical urological pathology during pregnancy (JJ catheter in place)
  • History of complex abdominal surgery
  • Impossibility or absence of obtaining free, informed and written consent, after a period of reflection
  • Patient not affiliated or beneficiary of a national health insurance system
  • Patient under legal protection, under guardianship or under curatorship
  • Patient having participated in interventional research on a drug within 3 months before inclusion
  • Patient participating in another interventional research
  • Patient in exclusion period determined by another study

About University Hospital, Montpellier

The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.

Locations

Montpellier, , France

Montpellier, , France

Nîmes, , France

Patients applied

0 patients applied

Trial Officials

Audrey LAMOUROUX, MD

Study Director

Montpellier University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported